Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients

Exclusion Criteria

• •Subjects with a hypersensitivity to biphasic insulin aspart or to any of the excipients. Particular attention should be paid to the drug interactions that are listed within the product local label.
• •Women who are pregnant, breast feeding or have the intention of becoming pregnant within the next 12 months.